Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14751 - 14775 of 14958 in total
CG0070 is investigated in clinical trials for treating bladder cancer. CG0070 is a solid. CG0070 can potentially destroy cancer cells by two different mechanisms: direct cell killing by the virus and immune-mediated cell killing stimulated by GM-CSF. CG0070, an oncolytic virus therapy with specificity for multiple cancers, has been evaluated...
Investigational
Matched Description: … can potentially destroy cancer cells by two different mechanisms: direct cell killing by the virus and
Experimental
MK-4965 is an HIV-1 reverse transcriptase inhibitor.
Experimental
LI 301 is an orally bio-available compound delivered in a fast melt mechanism with taste masking enabling it to be taken anytime without water. It has a novel mode of action combining both the light effect of a Selective Serotonin Reuptake Inhibitor ("SSRI")(most likely antagonistic at 5HT1a receptors) and antagonism...
Investigational
Matched Description: … of a Selective Serotonin Reuptake Inhibitor ("SSRI")(most likely antagonistic at 5HT1a receptors) and
BMS-903452 has been used in trials studying the treatment of Diabetes.
Investigational
Experimental
Illicit
Experimental
Experimental
Experimental
Displaying drugs 14751 - 14775 of 14958 in total